BioSpace News Archive

Press Releases

Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs

October 31, 2025
·
6 min read
Press Releases

Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

October 31, 2025
·
1 min read
Press Releases

Breckenridge announces launch of Everolimus Tablets, 1mg, generic version of Zortress®

October 31, 2025
·
1 min read
Press Releases

Immuron Announces Clinical Trial Update

October 31, 2025
·
11 min read
Press Releases

Calluna Pharma Announces U.S. FDA Orphan Drug Designation Granted to CAL101 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

October 31, 2025
·
3 min read
Press Releases

Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong

October 31, 2025
·
3 min read
Press Releases

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

October 31, 2025
·
8 min read
Press Releases

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025

October 31, 2025
·
7 min read
Press Releases

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox

October 31, 2025
·
4 min read
Press Releases

Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance

October 31, 2025
·
20 min read